Top Aussie biologist offers stem cell hope

Stem-cell cures for inherited blood disorders, HIV/AIDS and type 1 diabetes are on the way, says a leading Australian scientist.

Developing cloned human embryos

An Aussie scientist is optimistic stem cell cures are on the way for the most dreadful illnesses. (AAP)

A world-renowned Australian scientist is optimistic stem cell cures are on the way for some of the most dreadful illnesses.

Several promising clinical trials are taking place, says Professor Alan Trounson, who now heads California's multi-billion dollar stem cell agency.

He believes stem-cell cures for inherited blood disorders and HIV/AIDS are close.

"We are three, four, five years away," said Prof Trounson, who made the opening address to a NSW Stem Cell Network conference via video link on Friday.

A correction or cure for type 1 diabetes was almost certain, he told AAP in a telephone interview.

"Therapies are being trialled that are going to change things."

These included therapies for macular degeneration and there was important progress with some forms of cancer, he said.

"There are going to be big changes in the next five years."

He cautioned people against spending money on untested promises of miracle cures.

"Don't be tempted unless a treatment has a solid scientific basis and has approval by a regulatory body in its country."

Professor Bernie Tuch, a diabetes specialist and founder of the NSW Stem Cell Network, emphasised the need to provide patients with realistic hope rather than hype.

He was optimistic a stem cell-based therapy would replace insulin for type 1 diabetes in 10 to 20 years.

Initial trials could happen relatively quickly, but it could take a long time for an approved therapy to be widely used.

Prof Tuch said there was a need to rejuvenate Australia's stem cell industry.

The country was once a world leader in research, but was losing key people and production potential to overseas organisations.

"Australia is the birth place of innovative ideas in stem cell research and therapies and has demonstrated commercial success as the birthplace of the world's biggest stem cell company, Mesoblast," Prof Tuch said.

"We also have some of the most innovative research including success in clinical trials for treatment of a corneal eye disease at University of NSW and for treatment resistant Crohn's disease at the University of Western Australia."

But there were better commercial and investment opportunities abroad, he said.

"A collective effort is needed to push this industry forward."


Share

2 min read

Published

Updated

Source: AAP


Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world